BP000442-HIV-140: Recombinant HIV-2 Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-134: Recombinant HIV-2 gp32
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-135: Recombinant HIV-2 gp32, Biotin Labeled
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000443-HIV-137: Recombinant HIV-2 gp32, HRP Labeled
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-138: Recombinant HIV-2 gp36
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-139: Recombinant HIV-2 gp36 (390-702 a.a.)
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-151: Recombinant HIV-2 gp36, MBP Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000444-HIV-152: Recombinant HIV-2 gp36, His Tag
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISABP000445-HIV-002: Recombinant HIV-2 Protease
Source: E. coli-derived.
Predicted molecular mass: 10.7 kDa.